What is Leerink Partnrs Forecast for ACAD FY2026 Earnings?
ACAD Stock | USD 17.60 0.44 2.56% |
About 69 percent of all ACADIA Pharmaceuticals' shareholders are curious in acquiring. The analysis of the overall investor sentiment regarding ACADIA Pharmaceuticals suggests that quite a large number of traders are confidant. The current market sentiment, together with ACADIA Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use ACADIA Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
ACADIA Pharmaceuticals Inc. Equities researchers at Leerink Partnrs lifted their FY2026 earnings estimates for ACADIA Pharmaceuticals in a research report issued to clients and investors on Wednesday, November 6th. Leerink Partnrs analyst M. Goodman now forecasts that the biopharmaceutical company will earn 1.15 per share for the year, up from
Read at thelincolnianonline.com
![]() |
ACADIA Pharmaceuticals Current Investor Sentiment
Comfort Level 69
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use ACADIA Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward ACADIA Pharmaceuticals.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
ACADIA Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards ACADIA Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ACADIA Pharmaceuticals Historical Investor Sentiment
Investor biases related to ACADIA Pharmaceuticals' public news can be used to forecast risks associated with an investment in ACADIA. The trend in average sentiment can be used to explain how an investor holding ACADIA can time the market purely based on public headlines and social activities around ACADIA Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ACADIA Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ACADIA Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ACADIA Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals Fundamental Analysis
We analyze ACADIA Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACADIA Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACADIA Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
ACADIA Pharmaceuticals is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
ACADIA Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ACADIA Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of ACADIA Pharmaceuticals could also be used in its relative valuation, which is a method of valuing ACADIA Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
ACADIA Pharmaceuticals Related Equities
CABA | Cabaletta Bio | 39.23 | ||||
ATHA | Athira Pharma | 7.69 | ||||
FBIO | Fortress Biotech | 7.23 | ||||
RVPH | Reviva Pharmaceuticals | 6.33 | ||||
MDGL | Madrigal Pharmaceuticals | 3.17 | ||||
VKTX | Viking Therapeutics | 3.12 | ||||
BPMC | Blueprint Medicines | 2.03 | ||||
PTCT | PTC Therapeutics | 0.78 | ||||
TERN | Terns Pharmaceuticals | 0.36 | ||||
SRPT | Sarepta Therapeutics | 1.27 | ||||
KRYS | Krystal Biotech | 2.33 | ||||
AKRO | Akero Therapeutics | 5.32 | ||||
HEPA | Hepion Pharmaceuticals | 14.29 |
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |